lansoprazole has been researched along with Sarcopenia in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaburaki, S | 1 |
| Yoshimura, E | 1 |
| Miyamoto, Y | 1 |
| Imai, S | 1 |
| Kashiwagi, H | 1 |
| Ueno, H | 1 |
| Sugawara, M | 1 |
| Takekuma, Y | 1 |
1 other study available for lansoprazole and Sarcopenia
| Article | Year |
|---|---|
Hepatic drug metabolism in older people with body composition changes.
Topics: Aged; Body Composition; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Female; Hand Strength; Hum | 2022 |